A detailed history of First Horizon Advisors, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 249 shares of LEGN stock, worth $10,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares
249
Previous 249 -0.0%
Holding current value
$10,602
Previous $11,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$57.25 - $69.74 $400 - $488
7 Added 2.89%
249 $14,000
Q3 2023

Oct 27, 2023

BUY
$63.16 - $76.5 $252 - $306
4 Added 1.68%
242 $16,000
Q2 2023

Aug 03, 2023

BUY
$46.28 - $75.01 $231 - $375
5 Added 2.15%
238 $16,000
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $1,172 - $1,548
27 Added 13.11%
233 $11,000
Q4 2022

Feb 10, 2023

BUY
$38.8 - $55.46 $310 - $443
8 Added 4.04%
206 $10,000
Q3 2022

Nov 09, 2022

BUY
$38.15 - $57.1 $7,553 - $11,305
198 New
198 $8,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.